Evidence map›Paper›PMID 34131633›Full record

ArticleHemaSphere2021

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.

Lise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, Larissa Lordier, Mira El-Khoury, Caroline Marty, Jean-Christophe Ianotto, Hana Raslova, Stefan N Constantinescu, Martín Hernán Bonamino and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Lise SecardinInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Cintia Gomez LimiaPrograma de Carcinogênese Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Instituto National do câncer, Rio de Janeiro, Brazil.
Suzana da Silva-BeneditoInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Larissa LordierInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Mira El-KhouryInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Caroline MartyInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Jean-Christophe IanottoService Hématologie Clinique, Institut de Cancéro-Hématologie, CHRU de Brest, France.
Hana RaslovaInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Stefan N ConstantinescuLudwig Institute for Cancer Research, Brussels, Belgium.
Martín Hernán BonaminoPrograma de Carcinogênese Molecular, Coordenação de Pesquisa, Instituto Nacional de Câncer, Instituto National do câncer, Rio de Janeiro, Brazil.
William VainchenkerInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Barbara Monte-MorCentro de Transplante de Medula Óssea - Instituto Nacional de Câncer, Instituto National do câncer, Rio de Janeiro, Brazil.
Antonio Di StefanoInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Isabelle PloInstitut national de la santé et de la recherche médicale, Unité mixte de recherche 1287, Gustave Roussy, Equipe Labellisée Ligue Nationale Contre le Cancer, Villejuif, France.
Institut Gustave Roussy · FRInstituto Nacional do Câncer · BRLa Ligue Contre le Cancer · FRUniversité Paris-Saclay · FRCentre Hospitalier Régional Universitaire de Brest · FRde Duve Institute · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the calreticulin (

Identifiers

PMID34131633
PMCPMC8196125
OpenAlexW3165977750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.